Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.

Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B, Ramos AH, Saksena G, Baca SC, Baselga J, Tabernero J, Barretina J, Enzinger PC, Corso G, Roviello F, Lin L, Bandla S, Luketich JD, Pennathur A, Meyerson M, Ogino S, Shivdasani RA, Beer DG, Godfrey TE, Beroukhim R, Bass AJ.

Cancer Res. 2012 Sep 1;72(17):4383-93. Epub 2012 Jul 2.

2.

Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.

Yamada A, Fujii S, Daiko H, Nishimura M, Chiba T, Ochiai A.

Int J Oncol. 2011 Feb;38(2):345-53. doi: 10.3892/ijo.2010.868. Epub 2010 Dec 9.

PMID:
21165554
3.

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.

Liu WL, Guo XZ, Zhang LJ, Wang JY, Zhang G, Guan S, Chen YM, Kong QL, Xu LH, Li MZ, Song LB, Zeng MS.

BMC Cancer. 2010 Sep 1;10:467. doi: 10.1186/1471-2407-10-467.

4.

Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.

Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, Wang XL, Peng ZH.

J Cancer Res Clin Oncol. 2010 Jul;136(7):997-1006. doi: 10.1007/s00432-009-0745-7. Epub 2009 Dec 19.

PMID:
20024662
5.

Bmi-1, stem cells and cancer.

Jiang L, Li J, Song L.

Acta Biochim Biophys Sin (Shanghai). 2009 Jul;41(7):527-34. Review.

6.

Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma.

He XT, Cao XF, Ji L, Zhu B, Lv J, Wang DD, Lu PH, Cui HG.

World J Gastroenterol. 2009 May 21;15(19):2389-94.

7.

Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.

Yonemitsu Y, Imazeki F, Chiba T, Fukai K, Nagai Y, Miyagi S, Arai M, Aoki R, Miyazaki M, Nakatani Y, Iwama A, Yokosuka O.

Hum Pathol. 2009 Sep;40(9):1304-11. doi: 10.1016/j.humpath.2009.01.017. Epub 2009 Apr 22.

PMID:
19386347
8.

Expression of Bmi-1 is a prognostic marker in bladder cancer.

Qin ZK, Yang JA, Ye YL, Zhang X, Xu LH, Zhou FJ, Han H, Liu ZW, Song LB, Zeng MS.

BMC Cancer. 2009 Feb 19;9:61. doi: 10.1186/1471-2407-9-61.

9.

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.

Pietersen AM, Horlings HM, Hauptmann M, Langerød A, Ajouaou A, Cornelissen-Steijger P, Wessels LF, Jonkers J, van de Vijver MJ, van Lohuizen M.

Breast Cancer Res. 2008;10(6):R109. doi: 10.1186/bcr2214. Epub 2008 Dec 19.

10.

Expression and distribution patterns of the stem cell marker, nestin, and the stem cell renewal factor, BMI-1, in normal human nasal mucosa and nasal polyps.

Kim TH, Lee HM, Lee SH, Choe H, Kim HK, Lee JH, Oh KH, Lee SH.

Acta Otolaryngol. 2009 Sep;129(9):996-1001. doi: 10.1080/00016480802527560.

PMID:
19012049
11.

Bmi-1 expression predicts prognosis for patients with gastric carcinoma.

Liu JH, Song LB, Zhang X, Guo BH, Feng Y, Li XX, Liao WT, Zeng MS, Huang KH.

J Surg Oncol. 2008 Mar 1;97(3):267-72.

PMID:
18041745
12.

Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions.

Reinisch CM, Uthman A, Erovic BM, Pammer J.

J Cutan Pathol. 2007 Feb;34(2):174-80.

PMID:
17244030
13.

Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival.

Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, Park NH.

Br J Cancer. 2007 Jan 15;96(1):126-33. Epub 2006 Dec 19.

14.

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.

Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX.

Cancer Res. 2006 Jun 15;66(12):6225-32.

15.

Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.

Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Höfler H, Sarbia M.

J Clin Pathol. 2006 Jun;59(6):631-4.

17.

Global cancer statistics, 2002.

Parkin DM, Bray F, Ferlay J, Pisani P.

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

18.

Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer.

Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW.

Breast. 2004 Oct;13(5):383-8.

PMID:
15454193
19.

Stem cells and cancer; the polycomb connection.

Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M.

Cell. 2004 Aug 20;118(4):409-18. Review.

20.

The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins.

Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, Choe YK, Kim JW.

Cancer Lett. 2004 Jan 20;203(2):217-24.

PMID:
14732230

Supplemental Content

Support Center